A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
| Status: | Archived |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease, Hospital |
| Therapuetic Areas: | Nephrology / Urology, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2011 |
| End Date: | February 2013 |
Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
The purpose of this study is to determine if PRT-201 when applied to a limited segment of
your blood vessel (about 2 inches) immediately after surgery to create an arteriovenous
fistula is safe and improves the patency of your fistula. PRT-201 is a protein that has been
shown to help keep vessels open ("patent") when applied to the outside surface of the blood
vessels (arteries and veins) in AVF patients in a previous study.
We found this trial at
7
sites
850 Boylston Street
Chestnut Hill, Massachusetts 02467
Chestnut Hill, Massachusetts 02467
1-800-BWH-9999
Brigham & Women's Hospital Women's Health Center At Brigham and Women
Click here to add this to my saved trials
University of Iowa With just over 30,000 students, the University of Iowa is one of...
Click here to add this to my saved trials
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Houston Methodist Hospital Houston Methodist is comprised of a leading academic medical center in the...
Click here to add this to my saved trials
Click here to add this to my saved trials
Sentara Norfolk General Hospital Sentara Norfolk General Hospital is recognized as the number one ranked...
Click here to add this to my saved trials
Click here to add this to my saved trials